Isotroin
developed to mitigate severe acne, utilized to target sebum production and support long-term skin health.
Strengths: 10 · 20mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Roaccutane
- Therapeutic class
Retinoid
- Pharmacological class
Retinoid
- Minor side effects
dry skin; cheilitis; dry eyes
- Moderate side effects
arthralgia; myalgia; elevated liver enzymes
- Dosage forms
Capsule, soft
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Cipla Ltd
- Onset Time
2–4 weeks
- Duration
Ongoing
- Storage instructions
Store in a cool, dry place.
- Drug interactions
vitamin A supplements; tetracyclines; minocycline
- Age restrictions
Consult specialist for adolescents.
Contraindications
pregnancy; breastfeeding; severe hepatic impairment; hypervitaminosis A; severe hyperlipidaemia
Precautions and warnings
avoid prolonged sun and UV exposure; moisturise skin and lips regularly; report any mood changes immediately
Serious side effects
teratogenicity — requires immediate medical attention; depression — requires immediate medical attention; pseudotumour cerebri — requires immediate medical attention
Patient summary
developed to mitigate severe acne, utilized to target sebum production and support long-term skin health.
Mechanism of action
A retinoid that reduces sebum production by shrinking sebaceous glands, while also preventing the formation of blocked pores and reducing inflammation associated with acne.
Pregnancy and breastfeeding
Pregnancy: Absolutely contraindicated; causes severe birth defects. Breastfeeding: Do not use.
Isotroin
developed to mitigate severe acne, utilized to target sebum production and support long-term skin health.
Editorial Notes
- Active ingredient(s): Isotretinoin
- Listed indication(s): Acne Vulgaris
Usually available as
- 90 tablets - 10 mg1250-10-mg-14915
- 90 tablets - 20 mg1250-20-mg-14920